Brian J. Mog

Also affiliated with Johns Hopkins University, Johns Hopkins Medicine, Lustgarten Foundation, Sidney Kimmel Cancer Center, Sidney Kimmel Comprehensive Cancer Center

MedicineImmunology and MicrobiologyBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 17 papers. Top paper: “Transcriptional programs of neoantigen-specific TIL in anti-PD-1-treated lung cancers”.

Transcriptional programs of neoantigen-specific TIL in anti-PD-1-treated lung cancers

Nature(2021)10.1038/s41586-021-03752-4

N/A

0.948DataRank · unranked

555 citations

Jiajia Zhang, Zhicheng Ji, Ajay Vaghasia, Boyang Zhang, Emily Han-Chung Hsiue +50 more

TRBC1-targeting antibody–drug conjugates for the treatment of T cell cancers

Nature(2024)10.1038/s41586-024-07233-2

N/A

0.574DataRank · unranked

45 citations

Jiaxin Ge, Brian J. Mog, Bum Seok Lee, Alexander H. Pearlman, Michael S. Hwang +22 more

Structural engineering of chimeric antigen receptors targeting HLA-restricted neoantigens

Nature Communications(2021)10.1038/s41467-021-25605-4

N/A

0.553DataRank · unranked

39 citations

Michelle S. Miller, Puchong Thirawatananond, Jacqueline Douglass, Katharine M. Wright, Emily Han-Chung Hsiue +17 more

Precision targeting of autoreactive B cells in systemic lupus erythematosus using anti-9G4 idiotope synthetic immune receptor T cells

bioRxiv (Cold Spring Harbor Laboratory)(2025)10.1101/2025.10.19.682634

N/A

0.269DataRank · unranked

5 citations

Yuanxuan Xia, Brian J. Mog, Colin Gliech, Elana Shaw, Dylan P. Ferris +25 more

TRBC2-targeting antibody–drug conjugates for the treatment of T cell cancers

Nature Cancer(2025)10.1038/s43018-025-01069-z

N/A

0.165DataRank · unranked

2 citations

Joshua Urban, Sarah R. DiNapoli, Bum Seok Lee, Taha Ahmedna, Tushar D. Nichakawade +26 more

ME3BP-7 is a targeted cytotoxic agent that rapidly kills pancreatic cancer cells expressing high levels of monocarboxylate transporter MCT1

eLife(2024)10.7554/elife.94488

N/A

0.111DataRank · unranked

1 citations

Marco Dal Molin, Brian J. Mog, Gyuri Han, Evangeline Watson, Nicolas Wyhs +12 more

Hydrophobic interactions dominate the recognition of a KRAS G12V neoantigen

Nature Communications(2023)10.1038/s41467-023-40821-w

N/A

0DataRank · unranked

25 citations

Sarah R. DiNapoli, Michelle S. Miller, P. Aitana Azurmendi, Xiaowei Zhao, Zhiheng Yu +17 more

ME3BP-7 is a targeted cytotoxic agent that rapidly kills pancreatic cancer cells expressing high levels of monocarboxylate transporter MCT1

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.07.23.550207

N/A

0DataRank · unranked

1 citations

Marco Dal Molin, Brian J. Mog, Gyuri Han, Evangeline Watson, Nicolas Wyhs +12 more

Preclinical studies show that Co-STARs combine the advantages of chimeric antigen and T cell receptors for the treatment of tumors with low antigen densities

Science Translational Medicine(2024)10.1126/scitranslmed.adg7123

N/A

0DataRank · unranked

25 citations

Nikita Marcou, Sarah R. DiNapoli, Alexander H. Pearlman, Tushar D. Nichakawade, Michael S. Hwang +19 more

ME3BP-7 is a targeted cytotoxic agent that rapidly kills pancreatic cancer cells expressing high levels of monocarboxylate transporter MCT1

eLife(2024)10.7554/elife.94488.1

N/A

0DataRank · unranked

0 citations

Marco Dal Molin, Brian J. Mog, Gyuri Han, Evangeline Watson, Nicolas Wyhs +12 more

Engineering immunotoxin-equipped effector cells and evaluation in primary human immune cells

bioRxiv (Cold Spring Harbor Laboratory)(2025)10.64898/2025.12.09.691975

N/A

0DataRank · unranked

1 citations

Brian J. Mog, Michael S. Hwang, Jordina Rincón-Torroella, Sarah R. DiNapoli, Suman Paul +11 more

ME3BP-7 is a targeted cytotoxic agent that rapidly kills pancreatic cancer cells expressing high levels of monocarboxylate transporter MCT1

eLife(2025)10.7554/elife.94488.3

N/A

0DataRank · unranked

0 citations

Marco Dal Molin, Brian J. Mog, Gyuri Han, Evangeline Watson, Nicolas Wyhs +12 more

Targeting a neoantigen derived from a common TP53 mutation

Science(2021)10.1126/science.abc8697

N/A

0DataRank · unranked

350 citations

Katharine M. Wright, Jacqueline Douglass, Michael S. Hwang, Brian J. Mog, Alexander H. Pearlman +20 more

Targeting loss of heterozygosity for cancer-specific immunotherapy

Proceedings of the National Academy of Sciences(2021)10.1073/pnas.2022410118

N/A

0DataRank · unranked

75 citations

Brian J. Mog, Jacqueline Douglass, Alexander H. Pearlman, Emily Han-Chung Hsiue, Suman Paul +10 more

TCR β chain–directed bispecific antibodies for the treatment of T cell cancers

Science Translational Medicine(2021)10.1126/scitranslmed.abd3595

N/A

0DataRank · unranked

57 citations

Alexander H. Pearlman, Jacqueline Douglass, Brian J. Mog, Emily Han-Chung Hsiue, Michael S. Hwang +15 more

Improving the sensitivity of in vivo CRISPR off-target detection with DISCOVER-Seq+

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.10.29.514376

N/A

0DataRank · unranked

4 citations

Yang Liu, Oscar E. Reyes Gaido, Maximilian F. Konig, Brian J. Mog, Leo Shen +4 more

Improving the sensitivity of in vivo CRISPR off-target detection with DISCOVER-Seq+

Nature Methods(2023)10.1038/s41592-023-01840-z

N/A

0DataRank · unranked

44 citations

Yang Liu, Oscar E. Reyes Gaido, Maximilian F. Konig, Brian J. Mog, Leo Shen +4 more